OK thanks MerchantBanker. Unfortunately due to lockdown home schooling and other things I can't devote the time I'd like to to keeping fully abreast of developments. I decided I was over exposed here and cancelled my entitlement to 40p shares earlier today but now I'm wondering whether to reinstate it. Seems to have been oversold here today for anyone willing to hold until at least end of year.
Merchantbanker - you say 'Omega however post the placing investment will be able to make 2m tests per week' but the RNS today says 200,000 per week at the end of September. That's 10 times less than your figure ...... ???
Sneller is not selling down at all.. Dob't you even bother to read the RNS ? The 'An event changing the breakdown of voting rights' box is ticked - his allocation has altered due to th e placing.
Legin252 - the fact that it is out for testing suggests to me the DF is done ? You surely wouldn't be testing stuff if someone was also still fiddling with the design ? We know have to hope the tests show that it delivers all that it should .
alamo55 looks as though he has simply looked at the closing price on this site. Not a good idea as LSE is notoriously unreliable - for example today it missed off the last hour of trades here and the 3.90p price shown was the price at 15:24 !
They no longer hold a 'notifiable interest' it says. In reality that means simply they don't have to notify their remaining holding - I think the threshold for that is 3%. So we can't be totally sure they no longer hold any shares at all, though personally I think it is probable they are completely out
RE: Not ours but not the best of timing?25 Jun 2020 06:18
This is not 'BBC negativity' nskno1 - they are simply reporting a letter from 14 academics published in the British Medical Journal. And no, it will not do our share price any favours.